Home >> News >> Business >> Global Blood-Brain Barrier market report just published by Credence Research Inc.

Global Blood-Brain Barrier market report just published by Credence Research Inc.

The purpose of the report is to illustrate the state of the market of Blood Processing Devices and Consumables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026. [Continue Reading]

Market Insights:

The blood-brain barrier (BBB) plays important role in protecting the brain from toxic compounds and blood-borne disorders. Thus, in case of central nervous system diseases it is vital to get treatments across this barrier and deliver desired effect at targeted location. According to experts, more than 98% of small molecules drugs and nearly 100% of larger biologic drugs cannot enter the brain at adequate concentrations to project therapeutic effects. The three main BBB permeation mechanisms that occur are passive diffusion, endocytosis, and active transport. Passive diffusion occurs by two mechanisms free and facilitated, endocytosis occurs by bulk phase and facilitated, and active transport through influx and efflux.  Technological development has introduced several key approaches for brain targeting include transport mechanisms such as cell-mediated endocytosis, reticence of active efflux pumps, adsorptive-mediated transcytosis, receptor-mediated transport, and the use of peptide vectors. Drug delivery technologies comprise delivery with assistance of liposomes, nanoparticles, nanogels, dendrimers, nanoemulsions, micelles, exosomes, polymersomes, and quantum dots.

According to market experts, increasing prevalence of neurological diseases, growing geriatric population, rising healthcare expenditure, mounting investment in pharmaceutical research and development, high awareness associated with chronic neurological diseases, and supportive policies and awareness campaigns organized by government organizations are observed as the key driving factors for significant growth of blood-brain barrier market..[Continue Reading]

Leading Players:

Hoffmann La-Roche, Ltd., Ossianix, Inc., Eli Lilly And Company, Bristol-Myers Squibb Company, Sanofi Genzyme, biOasia Technologies, Inc., Envivo Pharmaceuticals, Inc., Sagetis Biotech, Janssen Pharmaceutica NV, and ArmaGen among others..

Browse here for full report with Toc: https://www.credenceresearch.com/report/blood-brain-barrier-market

Why was the report written?               


This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Blood-Brain Barrier buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?

Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.

The report on the market of Blood-Brain Barrier contains:

Analysis and forecast of Blood-Brain Barrier market dynamics;

Analysis of domestic production, market shares of the main market players;

Analysis of exports and imports;

Analysis of factors, leading the development of the Blood-Brain Barrier market;

Assessment and forecast of Blood-Brain Barrier market development;

Financial and business profiles of the leading companies in theBlood-Brain Barrier industry.


– Up to date working Blood-Brain Barrier data by major regions in the world, the forecast of planned capacity additions by 2026

– The annual breakdown of capital expenditure spending on proposed Blood-Brain Barrier for the period 2018 to 2026

– Planned Blood-Brain Barrier additions and capital expenditure spending by key countries and companies across the world

– Planned capital expenditure spending on new Blood-Brain Barrier projects by region, key countries, and companies

– Details of major planned Blood-Brain Barrier projects in the world up to 2026

Browse here for full report with Toc: https://www.credenceresearch.com/report/blood-brain-barrier-market

Also you can request us for sample in pdf with more details and graph:https://www.credenceresearch.com/sample-request/59234

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:                                                        

Credence Research Inc.

105 N 1st ST #429


CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290

Web: https://www.credenceresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *